The completion of the Series A marks a fast-moving year for Trogenix, which only emerged from stealth in November 2024. The ...

Support services are fundamentally important to CDMS vendor selection. Consider the story of this complex rescue study when ...

Through the FDA's ANDA scheme, drug manufacturers who test and produce their generic medicines on US soil can now seek ...

This culminated in a $500m funding cut to mRNA vaccine research funding, impacting around 22 projects being run at the ...

Researchers from McMaster University and MIT have discovered a new antibiotic to treat inflammatory bowel diseases (IBD).

Health Canada has approved Santhera Pharmaceuticals’ Agamree (vamorolone) drug for treating Duchenne muscular dystrophy (DMD) ...

Induced pluripotent stem cells (iPSCs) have the potential to usher in a new era of transformative medical treatments, capable ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Though unexpected CRLs issued by the FDA have caused ripples in the industry, Becky Wood believes that these cases are the ...

Genmab has signed an agreement to buy all shares of Merus at $97 per share, in an all-cash transaction valued at $8bn.

Rocket has pulled an approval application to the FDA, with the biotech considering offloading the asset via external ...

With decades of hands-on experience, Sharp’s industry experts reveal their top five recommendations for a timely and ...